Humacyte's ATEV product is being review by the FDA and originally set a priority date of 10th August 2024, but was later delayed due to the FDA needing extra time. It is approaching the 9 month mark now, so the big question now is, is the approval date close by? Looking at a past case we see the FDA does communicate at a 9-10month timeframe, so there is a chance we will hear from the FDA very soon about a review date.

Disclaimer: I am just an ordinary everyday investor and this is all just my own personal opinion and should not be relied upon for any investing decisions. Please do your own research or seek an authorised financial advisor. Video may contain inaccuracies and some of the information mentioned may have changed or may not be relevant at the time of watching.

свернуть